GSK-2245035

N/A

Report date: 2023/05/04 20:00:22
NME

Base Information

Drug NameGSK-2245035
Drug Alias NameGSK-2245035
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterferon alpha-2 stimulantsToll like receptor 7 agonists
TargetsInterferon alpha-2Toll like receptor 7
Therapy Area/IndicationsRhinitis, Allergic, SeasonalAsthmaRhinitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaNetherlandsGermany +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic, SeasonalAsthmaRhinitis

Other Information

ATC CodeN/A
Related LinksN/A